Skip to main content
logo
Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
302.30
+5.90 (1.99%)
At close: Aug 25, 2026

Aptus Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
5,1842,395----
Market Cap Growth
------
Enterprise Value
5,2462,334----
Last Close Price
302.30139.66----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
97.1451.85----
PS Ratio
11.135.14----
PB Ratio
22.2110.26----
P/TBV Ratio
22.2610.28----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
11.265.01----
EV/EBITDA Ratio
70.4431.34----
EV/EBIT Ratio
74.5233.15----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.310.311.492.722.021.48
Debt / EBITDA Ratio
0.960.962.143.333.374.49
Net Debt / Equity Ratio
0.260.260.742.251.531.17
Net Debt / EBITDA Ratio
0.830.831.062.762.553.56
Net Debt / FCF Ratio
-0.68-0.68-2.09-1.75-3.14-
Asset Turnover
1.421.421.542.202.723.18
Inventory Turnover
2.072.071.722.382.583.52
Quick Ratio
1.021.020.901.040.941.01
Current Ratio
1.831.831.632.031.821.74
Return on Equity (ROE)
30.48%30.48%70.99%56.41%24.95%18.71%
Return on Assets (ROA)
13.44%13.44%17.94%10.62%5.83%4.49%
Return on Invested Capital (ROIC)
22.65%24.52%36.70%22.33%15.03%9.82%
Return on Capital Employed (ROCE)
29.10%29.10%46.60%23.30%15.40%12.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
0.89%1.93%----
FCF Yield
-1.74%-3.78%----
Buyback Yield / Dilution
-295.82%-22.09%-224.21%-105.42%0.02%-16.87%